← All trials
NCT00484471
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2007
- Primary completion
- Nov 1, 2011
- Completion date
- Nov 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 127
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- OtsukaLead sponsor
- Siriraj HospitalOverall official - principal investigator
- Jinan UniversityOverall official - principal investigator
- Tsao-Tun Psychistric CenterOverall official - principal investigator
- National Center for Mental Health (NCMH)Overall official - principal investigator
- Somdej Chaophraya HospitalOverall official - principal investigator
- Castle Peak HospitalOverall official - principal investigator
- University of Sto. TomasOverall official - principal investigator
- Department of Veteran AffairsOverall official - principal investigator
- Changhua Christian HospitalStudy chair
- National Cheng Kung UniversityOverall official - principal investigator
- Government of TaiwanOverall official - principal investigator
- University of the PhilippinesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.